SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging
SCAN:标准化集中式阿尔茨海默病和相关痴呆症神经影像学
基本信息
- 批准号:9976317
- 负责人:
- 金额:$ 165.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAmyloidBig DataBiochemistryBiological MarkersBrainBrain imagingCaringCerebrumClinicalClinical TrialsCollectionComplexDataData CollectionData SetDatabasesDecision MakingDementiaDepositionDevelopmentDiagnosisDiagnosticDiffusionDiseaseDocumentationEnsureEpidemiologyEquipmentEvaluationGenetic DiseasesGlucoseGoalsImageIndividualInfrastructureLabelLaboratoriesLaboratory ResearchLeadLeadershipLinkMagnetic Resonance ImagingMeasurementMeasuresMethodsMissionModelingMultimodal ImagingNational Institute on AgingParticipantPatientsPerfusionPhenotypePlayPositron-Emission TomographyProceduresProtocols documentationPsychometricsQuality ControlRecommendationRegistriesReportingResearchResearch PersonnelResolutionResourcesRoleSamplingScienceSecureSleepStandardizationStructureSurveysTherapeutic StudiesThickTimeWhite Matter HyperintensityWorkabeta depositionage relatedbrain volumecerebral microbleedscerebrovascular lesioncerebrovascular pathologyclinical biomarkersclinical practicecommunity centercomorbiditycostdemographicsdesigngenetic epidemiologyglucose metabolismimage processingimaging modalityimprovedinnovationlarge datasetsmetabolic imagingmobile computingneuroimagingneuropathologynovelnovel strategiesopen sourceprogramsprospectiverepositorytau Proteinsvirtualweb site
项目摘要
PROJECT SUMMARY
This overall goal of this application is to create an infrastructure for supporting and augmenting neuroimaging
research in the National Institute of Aging’s Alzheimer’s Disease Centers (ADC) Program. The ADC program is
comprised of 30 centers that pursue research goals dedicated to increasing our understanding of Alzheimer’s
disease (AD) with a view towards improving diagnosis, care, and treatment of patients. Over the past decade,
neuroimaging has played an increasingly important role in this mission, as new approaches to measuring brain
structure, function, and biochemistry have produced biomarkers useful in diagnostic, mechanistic, and
therapeutic studies. At the same time, methods for standardization of neuroimaging have become accepted,
such that, despite the complexity and cost of imaging, we have the ability to combine images obtained at
different centers in order to answer important questions about AD that require large datasets. This project will
focus on standardizing approaches to magnetic resonance imaging (MRI) and positron emission tomography
(PET) images. MR standardization will address structural and functional (task-free) MRI, and PET
standardization will address amyloid, tau, and glucose metabolic imaging. We will work with the National
Alzheimer’s Coordinating Center (NACC) to develop protocols for securely uploading and de-identifying all
images at a NACC image repository, where a searchable database will also be available to researchers. We
will develop standards for MR and PET image acquisition, and make these imaging protocols available to the
ADC community. Uploaded images will undergo rigorous quality control and processing to permit merging of
images obtained on different platforms and, for PET, at different resolutions. Laboratories that have specialized
in image processing will produce numerical summary data of brain cerebrovascular pathology, brain volumes,
perfusion, diffusion, and cortical thickness, amyloid and tau deposition, and glucose metabolism. These
numerical variables will be stored at NACC where it will be linked to other ADC-related data on participants and
made available to researchers. Additional aspects of the program will include a website with documentation,
search functions, and user help functions. The administrative structure of the project will involve an executive
committee with membership from the participating laboratories as well as representation from the NACC, the
ADCs, and NIA. Leadership will remain apprised of changes in the neuroimaging landscape, and incorporate
new MR and PET measures as they develop with the overall goal of standardizing and disseminating agreed-
upon best practices while not stifling the development of new, innovative technical advances.
项目概要
该应用程序的总体目标是创建一个用于支持和增强神经成像的基础设施
国家老龄化研究所阿尔茨海默病中心 (ADC) 项目的研究 ADC 项目是。
由 30 个研究中心组成,致力于增进我们对阿尔茨海默病的了解
疾病(AD),以改善患者的诊断、护理和治疗在过去的十年中,
随着测量大脑的新方法的出现,神经影像学在这一任务中发挥着越来越重要的作用
结构、功能和生物化学产生了可用于诊断、机制和
与此同时,神经影像学标准化方法已被接受。
这样,尽管成像的复杂性和成本,我们仍然能够组合在以下位置获得的图像:
为了回答需要大量数据集的有关 AD 的重要问题,该项目将在不同的中心进行。
专注于磁共振成像 (MRI) 和正电子发射断层扫描方法的标准化
(PET) 图像标准化将解决结构和功能(无任务)MRI 和 PET 问题。
我们将与国家实验室合作解决淀粉样蛋白、tau 蛋白和葡萄糖代谢成像的标准化问题。
阿尔茨海默病协调中心 (NACC) 将开发安全上传和取消识别所有内容的协议
图像存储在 NACC 图像存储库中,研究人员也可以在该存储库中使用可搜索的数据库。
将制定 MR 和 PET 图像采集标准,并将这些成像协议提供给
ADC 社区上传的图像将经过严格的质量控制和处理,以允许合并。
在不同的平台上获得的图像,对于 PET,在不同的实验室具有专门的分辨率。
在图像处理中将产生脑脑血管病理学、脑体积、
灌注、扩散和皮质厚度、淀粉样蛋白和 tau 沉积以及葡萄糖代谢。
数值变量将存储在 NACC 中,并与参与者的其他 ADC 相关数据相关联
该计划的其他方面将包括一个包含文档的网站,
项目的管理结构将涉及执行人员。
委员会由参与实验室的成员以及 NACC、
ADC 和 NIA 领导层将继续了解神经影像领域的变化,并将其纳入其中。
新的 MR 和 PET 措施的制定总体目标是标准化和传播商定的
基于最佳实践,同时不抑制新的创新技术进步的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CLIFFORD R. JACK其他文献
CLIFFORD R. JACK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CLIFFORD R. JACK', 18)}}的其他基金
SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging
SCAN:标准化集中式阿尔茨海默病和相关痴呆症神经影像学
- 批准号:
10335694 - 财政年份:2020
- 资助金额:
$ 165.72万 - 项目类别:
SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging
SCAN:标准化集中式阿尔茨海默病和相关痴呆症神经影像学
- 批准号:
10400153 - 财政年份:2020
- 资助金额:
$ 165.72万 - 项目类别:
SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging
SCAN:标准化集中式阿尔茨海默病和相关痴呆症神经影像学
- 批准号:
10819797 - 财政年份:2020
- 资助金额:
$ 165.72万 - 项目类别:
Multiple System Atrophy - Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic Approach
多系统萎缩——早期诊断、病理生理学和治疗方法的新目标
- 批准号:
9113684 - 财政年份:2015
- 资助金额:
$ 165.72万 - 项目类别:
Multiple System Atrophy - Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic Approach
多系统萎缩——早期诊断、病理生理学和治疗方法的新目标
- 批准号:
9328184 - 财政年份:2015
- 资助金额:
$ 165.72万 - 项目类别:
Validating the New Criteria for Preclinical Alzheimer's disease
验证临床前阿尔茨海默病的新标准
- 批准号:
9037567 - 财政年份:2012
- 资助金额:
$ 165.72万 - 项目类别:
Validating the New Criteria for Preclinical Alzheimer's disease
验证临床前阿尔茨海默病的新标准
- 批准号:
8273143 - 财政年份:2012
- 资助金额:
$ 165.72万 - 项目类别:
Brain Aging and Alzheimer's Biomarker Classification Using Amyloid PET, tau PET, and Neurodegeneration on MRI: Developing the ATN system
使用淀粉样蛋白 PET、tau PET 和 MRI 神经变性进行脑衰老和阿尔茨海默病生物标志物分类:开发 ATN 系统
- 批准号:
10163755 - 财政年份:2012
- 资助金额:
$ 165.72万 - 项目类别:
Brain Aging and Alzheimer's Biomarker Classification Using Amyloid PET, tau PET, and Neurodegeneration on MRI: Developing the ATN system
使用淀粉样蛋白 PET、tau PET 和 MRI 神经变性进行脑衰老和阿尔茨海默病生物标志物分类:开发 ATN 系统
- 批准号:
9308121 - 财政年份:2012
- 资助金额:
$ 165.72万 - 项目类别:
Validating the New Criteria for Preclinical Alzheimer's disease
验证临床前阿尔茨海默病的新标准
- 批准号:
8828533 - 财政年份:2012
- 资助金额:
$ 165.72万 - 项目类别:
相似国自然基金
阿尔茨海默病高危风险基因加速认知老化的脑神经机制研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
β-羟丁酸通过hnRNP A1调控Oct4抑制星形胶质细胞衰老影响AD的发生
- 批准号:31900807
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
胰岛素抵抗导致神经元衰老的分子机制及在老年痴呆疾病中的作用研究
- 批准号:91849205
- 批准年份:2018
- 资助金额:200.0 万元
- 项目类别:重大研究计划
载脂蛋白E4基因加速认知老化的脑神经机制研究
- 批准号:31700997
- 批准年份:2017
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
慢性睡眠障碍引起阿尔茨海默病tau蛋白病理变化及其表观遗传学机制研究
- 批准号:81771521
- 批准年份:2017
- 资助金额:54.0 万元
- 项目类别:面上项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 165.72万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 165.72万 - 项目类别:
Ultra-precision clinical imaging and detection of Alzheimers Disease using deep learning
使用深度学习进行超精密临床成像和阿尔茨海默病检测
- 批准号:
10643456 - 财政年份:2023
- 资助金额:
$ 165.72万 - 项目类别:
Chronic Pain and Risk of Alzheimer's-Related Neurodegeneration
慢性疼痛和阿尔茨海默病相关神经变性的风险
- 批准号:
10644253 - 财政年份:2023
- 资助金额:
$ 165.72万 - 项目类别: